Quince Therapeutics, Inc. – NASDAQ:QNCX
Quince Therapeutics stock price today
$1.61
-0.31
-16.58%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Quince Therapeutics stock price monthly change
+148.01%
month
Quince Therapeutics stock price quarterly change
+148.01%
quarter
Quince Therapeutics stock price yearly change
+72.32%
year
Quince Therapeutics key metrics
Market Cap | 81.39M |
Enterprise value | N/A |
P/E | -1.06 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 0.50 |
PEG ratio | -0.02 |
EPS | -0.77 |
Revenue | N/A |
EBITDA | -25.84M |
Income | -30.28M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeQuince Therapeutics stock price history
Quince Therapeutics stock forecast
Quince Therapeutics financial statements
| Jun 2023 | 0 | -4.88M | |
|---|---|---|---|
| Sep 2023 | 0 | -5.35M | |
| Dec 2023 | 36K | -8.89M | -24705.56% |
| Mar 2024 | 0 | -11.14M |
| 2025 | 0 | -57.34M | |
|---|---|---|---|
| 2026 | 0 | -35.00M |
Analysts Price target
Financials & Ratios estimates
| 2022-11-09 | -0.17041 | -0.22 |
|---|
| Jun 2023 | 88836000 | 1.95M | 2.2% |
|---|---|---|---|
| Sep 2023 | 85386000 | 2.25M | 2.64% |
| Dec 2023 | 180204000 | 95.12M | 52.78% |
| Mar 2024 | 159292000 | 85.11M | 53.43% |
| Jun 2023 | -3.82M | -20.32M | 26K |
|---|---|---|---|
| Sep 2023 | -4.81M | 3.63M | 10K |
| Dec 2023 | -6.07M | 5.39M | 57K |
| Mar 2024 | -8.35M | 8.91M | 190K |
Quince Therapeutics alternative data
| Aug 2023 | 21 |
|---|---|
| Sep 2023 | 21 |
| Oct 2023 | 21 |
| Nov 2023 | 21 |
| Dec 2023 | 21 |
| Jan 2024 | 21 |
| Feb 2024 | 21 |
| Mar 2024 | 21 |
| Apr 2024 | 21 |
| May 2024 | 32 |
| Jun 2024 | 32 |
| Jul 2024 | 32 |
Quince Therapeutics other data
5.49%
-9.64%
of QNCX is owned by hedge funds
22
-21
1.83M
-3.54M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Mar 2023 | 0 | 1871 |
| Aug 2023 | 579814 | 0 |
| Nov 2023 | 28756 | 0 |
| Dec 2023 | 139628 | 0 |
| Quarter | Transcript |
|---|---|
| Q3 2013 7 Nov 2013 | Q3 2013 Earnings Call Transcript |
| Q2 2013 6 Aug 2013 | Q2 2013 Earnings Call Transcript |
| Q1 2013 9 May 2013 | Q1 2013 Earnings Call Transcript |
| Q4 2012 14 Mar 2013 | Q4 2012 Earnings Call Transcript |
-
What's the price of Quince Therapeutics stock today?
One share of Quince Therapeutics stock can currently be purchased for approximately $1.61.
-
When is Quince Therapeutics's next earnings date?
Unfortunately, Quince Therapeutics's (QNCX) next earnings date is currently unknown.
-
Does Quince Therapeutics pay dividends?
No, Quince Therapeutics does not pay dividends.
-
How much money does Quince Therapeutics make?
Quince Therapeutics has a market capitalization of 81.39M. Quince Therapeutics made a loss 31.39M US dollars in net income (profit) last year or -$0.22 on an earnings per share basis.
-
What is Quince Therapeutics's stock symbol?
Quince Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "QNCX".
-
What is Quince Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Quince Therapeutics?
Shares of Quince Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Quince Therapeutics have?
As Jul 2024, Quince Therapeutics employs 32 workers, which is 52% more then previous quarter.
-
When Quince Therapeutics went public?
Quince Therapeutics, Inc. is publicly traded company for more then 6 years since IPO on 9 May 2019.
-
What is Quince Therapeutics's official website?
The official website for Quince Therapeutics is quincetx.com.
-
Where are Quince Therapeutics's headquarters?
Quince Therapeutics is headquartered at 601 Gateway Blvd, South San Francisco, CA.
-
How can i contact Quince Therapeutics?
Quince Therapeutics's mailing address is 601 Gateway Blvd, South San Francisco, CA and company can be reached via phone at +41 59105717.
Quince Therapeutics company profile:
Quince Therapeutics, Inc.
quincetx.comExchange:
NASDAQ
Full time employees:
32
Industry:
Biotechnology
Sector:
Healthcare
Quince Therapeutics, Inc., a biopharmaceutical company, focuses on advancing precision therapeutics for debilitating and rare diseases. The company has discovered a broad bone-targeting drug platform to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease. Its lead compound is NOV004, an anabolic peptide engineered to precisely target and concentrate at the bone fracture site The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.
601 Gateway Blvd
South San Francisco, CA 94080
South San Francisco, CA 94080
CIK: 0001662774
ISIN: US22053A1079
CUSIP: 22053A107
